 Vancouver, British Columbia and Minneapolis, Minnesota--Newsfile Corp. - February 2, 2021 - Neovasc, Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company today announced that the German Institute for the Hospital Remuneration SystemInEK has awarded the Neovasc ReducerTM Reducer, a CE-Marked medical device for the treatment of refractory angina, NUB Status 1 designation once again for 2021. New examination and treatment methods NUBs are comprised of novel and innovative medicines, medical products and procedures... 